Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06102928
Status:
RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-10-22
Brief Title:
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation
Sponsor:
Kunming Medical University
Organization:
Kunming Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-22
First Submit QC Date:
October 22 2023
Study First Post Date:
2023-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-22
Last Update Post Date:
2023-10-26
Last Update Post Date Type:
ACTUAL